BIFOSFONATOS EN ODONTOLOGIA PDF

Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Gardale Groran
Country: Anguilla
Language: English (Spanish)
Genre: Love
Published (Last): 6 December 2004
Pages: 236
PDF File Size: 9.48 Mb
ePub File Size: 11.86 Mb
ISBN: 660-4-80984-978-7
Downloads: 16665
Price: Free* [*Free Regsitration Required]
Uploader: Vijora

Unusual mid-shaft fractures during long term bisphosphonate therapy. N Engl J Med,pp.

BIFOSFONATO FINAL by Fabiola González on Prezi

Am J Gastroenterol ; Osteonecrosis of the jaws asociate with use of risedronate: BoneKey ; 6 The use of bisphosphonates in elderly cancer patients.

Association of low-energy femoral fractures with prolonged bisphosphonate use: Rheum Dis Clin North Am ; J Orthop Trauma ; 22 5: Bisphosphonates and osteonecrosis of the jaws: Arch Intern Med ; 3: The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.

  CLASIFICACION AO DE FRACTURAS PDF

Semin Oncol ; Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid. Low energy femoral fractures associated with the long-term use of bisphosphonates: Mehta RS, Chwistek M. JCDA, 73pp.

Bisphosphonate-induced avascular osteonecrosis of the jaws: J Oral Maxillofac Surg, 63pp. Pelayo M, Agra Y. Oral post-surgical complications following the administration of bisphosphonates given for osteopenia related to malignancy.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

Macarol V, Fraunfelder FT. Entre los factores de riesgo destacan: J Endod, 31pp.

The differences between various biphosphonates are in the safety margin between their inhibitor effect for bone resorption and the inhibitor effect for mineralization; bone resorption inhibition has been their most widely spread application.

Bilateral acute anterior uveitis after alendronate. Am J Hematol ; En general bifosfoonatos controla bastante bien con el tratamiento adecuado aunque su tendencia ‘natural’ es a cronificarse.

Survey of members of myeloma UK on biphosphontes associated jaw osteonecrosis. La eficacia demostrada de tratamientos con dosis oral de 70 mg de alendronato una vez por semana 11 puede facilitar el cumplimiento del tratamiento. Medina 2 y L.

  GEMHVO MV PDF

Naveau A, Naveau B. Is bisphosphonate-associated bifosfonatls of the jaw caused by soft tissue toxicity?

Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: Drug Saf ; 29 2: J Am Dent Assoc ; Bisphosphonates and osteonecrosis of the jaw: The mandible is more commonly affected than the maxilla. Risk factors, recognition, prevention, treatment of bisphosphonate-induced osteonecrosis of the jaws.

Support Cancer Ther ; 3: Rev Esp Cir Oral Maxilofac ; 30 odontolohia

Author: admin